Business
Only 40% of Australians want the AstraZeneca vaccine. What could this mean for CSL (ASX:CSL)?
New data reveals that only 40% of Australians are willing to take the AstraZeneca plc (LSE: AZN) COVID-19 vaccine. What, if anything, could this mean for CSL Limited (ASX: CSL)?. The data, released Monday in an Essential Research poll, comes at an inopportune time for the country as a whole, with the inoculation roll-out already delayed.
With CSL being the main manufacturer and distributor of the AstraZeneca vaccine in Australia, it would be interesting to know what the company makes of the latest figures.
Let’s take a closer look at the data.
1 in 5 Australian women refuse to get vaccinated
Since…
-
General21 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General11 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
General8 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
General15 hours agoForests, finance, fossils: climate talks hit full steam